Dow Up 0.76% Nasdaq Up 0.69%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
53.97 Down 0.16(0.30%) Oct 24, 4:00PM EDT
|After Hours : 54.41 Up 0.44 (0.82%) Oct 24, 6:06PM EDT
Prev Close:54.13
Open:54.35
Bid:N/A
Ask:67.87 x 500
1y Target Est:90.70
Beta:1.56
Next Earnings Date:27-Oct-14LGND Earnings announcement
Day's Range:52.84 - 54.35
52wk Range:41.99 - 80.42
Volume:406,521
Avg Vol (3m):432,356
Market Cap:1.12B
P/E (ttm):149.50
EPS (ttm):0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LGNDDown 0.30%1.12B
LLYUp 2.64%70.79B
MRKUp 1.73%166.18B
RHHBYDown 0.19%248.56B

Key Statistics

Forward P/E (1 yr):22.49
P/S (ttm):20.71
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.54
Quarterly EPS Est (Sep-14) :0.31
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.17

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback